UnitedHealth Group Incorporated $UNH Shares Bought by Davis Selected Advisers

Davis Selected Advisers lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2,234.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,132,885 shares of the healthcare conglomerate’s stock after buying an additional 1,084,366 shares during the period. UnitedHealth Group makes up 1.9% of Davis Selected Advisers’ holdings, making the stock its 18th biggest position. Davis Selected Advisers’ holdings in UnitedHealth Group were worth $353,426,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Brighton Jones LLC increased its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Parcion Private Wealth LLC boosted its position in shares of UnitedHealth Group by 3.2% during the 1st quarter. Parcion Private Wealth LLC now owns 1,199 shares of the healthcare conglomerate’s stock valued at $628,000 after acquiring an additional 37 shares during the last quarter. SeaBridge Investment Advisors LLC acquired a new stake in UnitedHealth Group during the first quarter worth about $204,000. Finally, Verdence Capital Advisors LLC boosted its holdings in UnitedHealth Group by 10.2% in the 1st quarter. Verdence Capital Advisors LLC now owns 18,769 shares of the healthcare conglomerate’s stock valued at $9,830,000 after purchasing an additional 1,732 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.9%

Shares of UNH stock opened at $332.53 on Friday. The stock has a market capitalization of $301.22 billion, a P/E ratio of 17.36, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $622.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The company has a 50 day moving average price of $347.53 and a 200 day moving average price of $320.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $7.15 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on UNH. Mizuho lifted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. Bank of America upped their price target on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Royal Bank Of Canada increased their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Finally, Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.